日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

MALDI Matrix: Origins, Innovations, and Frontiers

MALDI矩阵:起源、创新与前沿

Wu, Ran; Liu, Rui; Hu, Hao; Qin, Liang; Chen, Lulu; Bao, Zhibin; Fu, Jinxiang; Guo, Hua; Wang, Lei; Wang, Anna; Wang, Zihan; Yang, Chenyu; Cheng, Xiangrui; Chen, Difan; Liu, Haiqiang; Jing, Yanping; Guo, Shuai; Fu, Yujie; Wang, Xiaodong

Beyond the Sequence: Chemical and Topological Design and Innovations in mRNA Therapeutics

超越序列:mRNA疗法的化学和拓扑设计与创新

Liu, Dangliang; Chen, Hongyu; Pan, Alisia; Wang, Xiao

Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity

针对A型血友病的I期试点研究:AAV8载体联合预防性他克莫司-糖皮质激素治疗可达到治疗性FVIII活性。

Liu, Wei; Pei, Xiaolei; Yu, Tenghui; Xu, Bingqi; Dai, Xinyue; Xue, Feng; Chen, Lingling; Wang, Xiaolin; Wang, Yuhua; Chen, Yunfei; Liu, Xiaofan; Fu, Rongfeng; Wang, Wentian; Chi, Ying; Li, Hui Yuan; Yang, Renchi; Zhang, Lei

The consensus molecular subtypes of esophageal squamous cell carcinoma

食管鳞状细胞癌的共识分子亚型

Cui, Heyang; Zhu, Zhongxu; Xu, Enwei; Qi, Lin; Cheng, Yikun; Zhang, Yinghan; Zhang, Ling; Cheng, Matthew Yibo; Yang, Bin; Sun, Ruifang; Zhuang, Xiaofei; Xi, Yanfeng; Yan, Ting; Cheng, Caixia; Ding, Ning; Liu, Huijuan; Wang, Lu; Guo, Min; Guo, Dinghe; Zhang, Haoyu; Peng, Meilan; An, Zhekun; Weng, Yongjia; Wang, Fang; Liu, Meng; Xiong, Ruixin; Yin, Weihua; Song, Bin; Zhang, Weimin; Cheng, Xiaolong; Liu, Zhihua; Zhan, Qimin; Wang, Xin; Cui, Yongping

Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial

围手术期以 Penpulimab 为基础的联合疗法治疗可切除非小细胞肺癌患者(ALTER-L043):一项开放标签、多中心、随机、II 期试验

Wang, Meng; Liu, Weiran; Guo, Hongbo; Long, Hao; Yu, Bentong; Zhao, Guofang; Wu, Jun; Yue, Dongsheng; Zhao, Xiaoliang; Li, Chenguang; Zhang, Lianmin; Wang, Shengguang; Zhang, Qiang; Zhang, Zhenfa; Wang, Changli

PRIME-HFrEF Trial: a randomized, double-blind, multi-dose umbilical cord-derived mesenchymal stem cell regimen for heart failure

PRIME-HFrEF试验:一项针对心力衰竭的随机、双盲、多剂量脐带间充质干细胞治疗方案

Han, Wei; Jiao, Yuheng; Chen, Wei; Gong, Xin; Hu, Hao; Xin, Yuanfeng; Guan, Sibin; Zhao, Jun; Zhang, Qi; Yang, Bing; Pan, Jingwei; Wang, Haiyan; Lu, Qing; Chu, Shuguang; Cai, Dihui; Zheng, Liang; Jia, Wenwen; He, Zhiying; Yang, Huangtian; Sun, Yi Eve; Liu, Zhongmin

Ulcerative colitis: signaling pathways, therapeutic targets and interventional strategies

溃疡性结肠炎:信号通路、治疗靶点和干预策略

Jia, Jinhao; Liu, Ying; Wang, Dan; Pan, Zhaohai; Zheng, Qiusheng; Lu, Jun; Liang, Chao; Li, Defang

A novel necroptosis pathway: orchestrated by non-canonical STING-ZBP1 signaling

一种新型坏死性凋亡通路:由非经典STING-ZBP1信号通路调控

Zhu, Xiangyu; Liu, Sijia; Zhang, Long

Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis

Claudin18.2特异性IL-7/XCL1修饰的CAR-T细胞在消化道癌症中的疗效和免疫调节作用:临床前和临床分析

Zhao, Xuan; Liu, Jinyan; Zhang, Zhen; Zhou, Yali; Jin, Shuiling; Zong, Hong; Wang, Feng; Song, Min; Zhong, Yali; Li, Qinglong; Pei, Bo; Yu, Yong; Gao, Ming; Ge, Wengang; Han, Lu; Ren, Jiangtao; Zhang, Yi